The N=1 Collaborative is changing the way we view drug development. Their specialty is creating customized therapies tailored to individual patients, paving the way for a unique approach that can leave long-lasting impacts on those with ultra-rare diseases.  

 

Join us as Executive Director Hugh Hempel discusses the origins of N=1, the collaborative effort it takes to advance customized therapies down the pipeline, and what the future holds for the field of individualized medicine.

Show Notes  

  

n=1 Collaborative 

Rare Disease | Charles River 

Rare Disease Research for Drug Development 

Repurposing Drugs for Rare Disease 

S4 E07: Free For Life: The Story of N-Lorem Foundation